| Literature DB >> 30104633 |
Lela Kardava1, Haewon Sohn2, Christine Youn1, James W Austin1, Wei Wang1, Clarisa M Buckner1, J Shawn Justement1, Valerie A Melson1, Gwynne E Roth2, Marissa A Hand1, Kathleen R Gittens3, Richard W Kwan3, Michael C Sneller1, Yuxing Li4,5, Tae-Wook Chun1, Peter D Sun2, Susan K Pierce2, Susan Moir6.
Abstract
Immunoglobulin G3 (IgG3) has an uncertain role in the response to infection with and vaccination against human immunodeficiency virus (HIV). Here we describe a regulatory role for IgG3 in dampening the immune system-activating effects of chronic HIV viremia on B cells. Secreted IgG3 was bound to IgM-expressing B cells in vivo in HIV-infected chronically viremic individuals but not in early-viremic or aviremic individuals. Tissue-like memory (TLM) B cells, a population expanded by persistent HIV viremia, bound large amounts of IgG3. IgG3 induced clustering of B cell antigen receptors (BCRs) on the IgM+ B cells, which was mediated by direct interactions between soluble IgG3 and membrane IgM of the BCR (IgM-BCR). The inhibitory IgG receptor CD32b (FcγRIIb), complement component C1q and inflammatory biomarker CRP contributed to the binding of secreted IgG3 onto IgM-expressing B cells of HIV-infected individuals. Notably, IgG3-bound TLM B cells were refractory to IgM-BCR stimulation, thus demonstrating that IgG3 can regulate B cells during chronic activation of the immune system.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30104633 PMCID: PMC6289069 DOI: 10.1038/s41590-018-0180-5
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606